Header graphic for print

The Healthcare Investor

Insights on Issues & Trends that Impact Investments in Healthcare & Life Science Businesses

Healthcare & Life Sciences Private Equity Deal Tracker: Pharos Capital Acquires Providence Home Health and Hospice

Posted in Healthcare Services Investing

Pharos Capital Group has announced its post-acute care provider platform, Charter Health Care Group, has acquired The Providence Hospice and The Providence Home Health Services, together referred to as Providence Home Health and Hospice.

Providence Home Health and Hospice, based in Sugar Land, Texas, is a provider of in-home hospice, palliative care, skilled nursing, physical therapy and other related services. Founded in 2006, the company provides hospice and home health services to patients and their families in nearly 100 communities in the Greater Houston area.

Pharos Capital Group, with offices in Dallas and Nashville, pursues control equity and mezzanine investments in lower and middle market companies primarily in healthcare and business services. Founded in 1998, the firm targets the provider services and non-reimbursement industries within healthcare.

Terms of the acquisition were not disclosed.

TweetLikeEmailLinkedIn
Comments Off on Healthcare & Life Sciences Private Equity Deal Tracker: Pharos Capital Acquires Providence Home Health and Hospice

Healthcare & Life Sciences Private Equity Deal Tracker: KKR to Acquire Therapy Brands

Posted in Healthcare Services Investing

KKR has announced it has agreed to acquire a majority interest in Therapy Brands.

Therapy Brands, headquartered in Birmingham, Ala., is a practice management and electronic health record software platform for mental, behavioral, substance use recovery, applied behavior analysis and physical rehabilitation healthcare providers. Founded in 2013, the company supports more than 28,000 practices across the United States.

The PE platform of Kohlberg Kravis Roberts (KKR) & Co., which is based in New York, considers investments in all industries, including healthcare. Founded in 1976, the firm prefers to invest in a range of debt and public equity investing and may co-invest, seeking a controlling ownership of a company or a strategic minority positions.

KKR acquired Therapy Brands from its existing shareholders: investment funds affiliated with Lightyear Capital, Oak HC/FT and Greater Sum Ventures.

Terms of the acquisition were not disclosed.

TweetLikeEmailLinkedIn
Comments Off on Healthcare & Life Sciences Private Equity Deal Tracker: KKR to Acquire Therapy Brands

Healthcare & Life Sciences Private Equity Deal Tracker: RiverGlade Acquires Home Helpers Home Care From Linsalata

Posted in Healthcare Services Investing

RiverGlade Capital has acquired H.H. Franchising Systems from Linsalata Capital Partners, according to a news release.

H.H. Franchising, based in Cincinnati-based, operates Home Helpers Home Care. Home Helpers is a provider of in-home care to seniors and others. It has independently owned and operated offices in more than 1,000 U.S. communities.

RiverGlade Capital, based in Chicago, makes control and select minority equity investments in lower middle market healthcare companies. Founded in 2017, the firm prefers to make more substantial investments from a dollars perspective.

Linsalata Capital Partners, based in Mayfield Heights, Ohio, is a middle market private equity firm. Founded in 1984, the firm targets companies in healthcare and a few other industries.

Terms of the acquisition were not disclosed.

TweetLikeEmailLinkedIn
Comments Off on Healthcare & Life Sciences Private Equity Deal Tracker: RiverGlade Acquires Home Helpers Home Care From Linsalata

Healthcare & Life Sciences Private Equity Deal Tracker: H.I.G. Capital Invests in Concord USA

Posted in Healthcare Services Investing

H.I.G. Capital has announced it has completed a growth investment in Concord USA.

Concord, based in Minneapolis, provides technology consulting and digital services to customers in healthcare and a few other sectors. Founded in 2003, the company offers a suite of solutions within cloud applications and integration, data and analytics, information security, digital and user experience, and advisory services.

In connection with H.I.G.’s investment, Concord acquired Upton Hill, a Minnesota-based healthcare-focused consulting firm.

H.I.G. Capital, based in Miami, pursues a wide range of investments in healthcare and many other industries. Founded in 1993, the firm has flexibility on investment size, including interest in pre-EBITDA businesses. Within healthcare, the firm targets companies in the provider services, hospital/major facilities and life sciences/pharmaceutical industries.

Terms of the investment and acquisition were not disclosed.

TweetLikeEmailLinkedIn
Comments Off on Healthcare & Life Sciences Private Equity Deal Tracker: H.I.G. Capital Invests in Concord USA

Genstar Capital Closes Fund With $10.2 Billion

Posted in Healthcare Services Investing

Genstar Capital has announced it has closed its latest fund — Genstar Capital Partners X — with $10.2 billion in total commitments.

The fund reached its hard cap and was oversubscribed, the firm reported.

Genstar also announced that it raised committed overage capacity of $1.5 billion from select limited partners for Genstar’s Opportunities Fund X. This fund will co-invest in Genstar Capital Partners X’s larger transactions.

Genstar Capital, based in San Francisco, is a private equity firm focused on making control investments in global middle market companies headquartered in North America. Founded in 1988, the firm targets investments in healthcare and a few other sectors.

Healthcare & Life Sciences Private Equity Deal Tracker: Aurora Capital Acquires Bay Medical Waste Services From Summer Street Capital

Posted in Healthcare Services Investing

Aurora Capital Partners has announced it has acquired Curtis Bay Medical Waste Services from Summer Street Capital Partners.

Curtis Bay Medical Waste Services, based in Baltimore, is a provider of medical waste collection, treatment and disposal services. Founded in 1991, the company operates several autoclaves, a hauling network comprised of a company truck fleet and transfer stations, and a medical waste incinerator.

Aurora Capital, based in Los Angeles, is a middle market private equity firm focused on control investments. Founded in 1991, Aurora targets businesses valued between $100 and $500 million in three sectors: industrial and business services, industrial technologies, and software and tech-enabled services.

Summer Street Capital, based in Orchard Park, N.Y., is a private equity fund manager focused on investing in small and middle market companies. Founded in 1999, Summer Street Capital targets businesses valued between $20 million and $150 million in three sectors: niche manufacturing, environmental services and business services.

Terms of the acquisition were not disclosed.

TweetLikeEmailLinkedIn
Comments Off on Healthcare & Life Sciences Private Equity Deal Tracker: Aurora Capital Acquires Bay Medical Waste Services From Summer Street Capital

Healthcare & Life Sciences Private Equity Deal Tracker: Northlane Capital Invests in Empower Community Care

Posted in Healthcare Services Investing

Northlane Capital Partners (NCP) has announced it has completed an investment in Empower Community Care.

Empower, based in Atlanta, is a behavioral health organization that distributes evidence-based programs and technologies. The company provides services in 45 states and 17 countries. Empower is the parent company of MST Services, Orbis Partners and Evidence Based Associates.

NCP, based in Bethesda, Md., is a middle market private equity firm focused on healthcare and business services. Founded in 2003, the firm seeks investments in North American companies with EBITDA of $5 million to $30 million.

Terms of the investment were not disclosed.

TweetLikeEmailLinkedIn
Comments Off on Healthcare & Life Sciences Private Equity Deal Tracker: Northlane Capital Invests in Empower Community Care

Healthcare & Life Sciences Private Equity Deal Tracker: WindRose to Sell myNEXUS to Anthem

Posted in Healthcare Services Investing

WindRose Health Investors is leading an investor group selling myNEXUS to health benefits company Anthem, according to a news release.

myNEXUS, based in Brentwood, Tenn., manages home-based nursing services for payors. The company states that it delivers integrated clinical support services for approximately 1.7 million Medicare Advantage members across 20 states.

WindRose, which is based in New York, pursues control equity investments in healthcare companies. Founded in 2000, the firm invests in a broad range of industry segments, including outsourced services to payors and health systems, technology-enabled services, healthcare providers and value-added distribution.

The acquisition is expected to close in the second quarter of 2021 subject to customary regulatory approvals.

TweetLikeEmailLinkedIn
Comments Off on Healthcare & Life Sciences Private Equity Deal Tracker: WindRose to Sell myNEXUS to Anthem

Healthcare & Life Sciences Private Equity Deal Tracker: Avista Capital Partners to Invest in eMolecules

Posted in Healthcare Services Investing

Avista Capital Partners has announced it has signed a definitive agreement to invest in eMolecules.

eMolecules, based in San Diego, is provider of high-value, hard-to-find chemicals and bioreagents used in early-stage drug discovery research. Founded in 2005, the company connects pharmaceutical and biotechnology researchers with reagents not offered by the usual commodity suppliers.

Avista Capital Partners, based in New York, makes control buyout investments in middle market healthcare companies. Founded in 2005, the firm focuses on the following healthcare subsectors: pharmaceuticals, medical devices, outsourced pharmaceutical services, distribution and consumer-driven healthcare.

Terms of the acquisition were not disclosed.

TweetLikeEmailLinkedIn
Comments Off on Healthcare & Life Sciences Private Equity Deal Tracker: Avista Capital Partners to Invest in eMolecules

RiverVest Venture Partners Closes Life Sciences Fund With $275 Million

Posted in Life Sciences Investing

RiverVest Venture Partners has announced it has closed its fifth fund — RiverVest Venture Fund V — with $275 million of capital commitments.

RiverVest, based in St. Louis, Mo., is a venture capital firm that targets investments in early-stage biopharma and medical device companies.

Fund V is RiverVest’s largest fund to date. With the fifth fund, which was oversubscribed, RiverVest’s total assets under management now exceed $1.6 billion.

The firm noted that it has invested in 55 companies and founded 15 companies.

TweetLikeEmailLinkedIn
Comments Off on RiverVest Venture Partners Closes Life Sciences Fund With $275 Million

We use cookies to enhance your experience of our website. By continuing to use this website, you agree to the use of these cookies. For more information and to learn how you can change your cookie settings, please see our policy.

Agree